Literature DB >> 24141174

Appropriate use of special stains for identifying Helicobacter pylori: Recommendations from the Rodger C. Haggitt Gastrointestinal Pathology Society.

Kenneth P Batts1, Scott Ketover, Sanjay Kakar, Alyssa M Krasinskas, Kisha A Mitchell, Rebecca Wilcox, Maria Westerhoff, Joseph Rank, Joanna Gibson, Anthony R Mattia, Oscar W Cummings, Jon M Davison, Bita V Naini, Sarah M Dry, Rhonda K Yantiss.   

Abstract

Helicobacter pylori is a major cause of gastroduodenal injury, gastric cancer, and lymphoma, and, thus, there is great interest in its detection and eradication. Several detection methods are available, including histochemical and immunohistochemical stains. Application of these stains in clinical practice is heterogenous, to say the least. Although they were developed to enhance H. pylori detection, changing practice models, financial considerations, and a perceived need for rapid case turnaround have led to their widespread use in routine staining studies ordered reflexively on all gastric biopsies. Emerging data suggest that most of these stains are not needed to establish a diagnosis of H. pylori infection, and their added value when biopsies show minimal, or no, inflammation is not clear. In this manuscript, the Rodger C. Haggitt Gastrointestinal Pathology Society puts forth recommendations regarding ancillary stain usage for H. pylori detection based upon critical literature review and collective experience. Pathologists rarely, if ever, detect H. pylori in "normal" biopsies, but readily observe them in optimally stained hematoxylin and eosin sections from infected patients. Therefore, we suggest that use of ancillary stains is appropriate when biopsies show chronic, or chronic active, gastritis without detectable H. pylori in hematoxylin and eosin-stained sections, but performing them "up front" on all gastric biopsies is generally unnecessary. Application of these stains to nongastric biopsies and polyps is appropriate in an extremely limited set of circumstances. It is our hope that recommendations provided herein will provide helpful information to gastroenterologists, pathologists, and others involved in the evaluation of patients for possible H. pylori infection.

Entities:  

Mesh:

Year:  2013        PMID: 24141174     DOI: 10.1097/PAS.0000000000000097

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  13 in total

1.  Real-world Helicobacter pylori diagnosis in patients referred for esophagoduodenoscopy: The gap between guidelines and clinical practice.

Authors:  Dor Shirin; Shay Matalon; Benjamin Avidan; Efrat Broide; Haim Shirin
Journal:  United European Gastroenterol J       Date:  2016-01-08       Impact factor: 4.623

2.  Low Yield and High Cost of Gastric and Duodenal Biopsies for Investigation of Symptoms of Abdominal Pain During Routine Esophagogastroduodenoscopy.

Authors:  Eric M Nelsen; Abby Lochmann-Bailkey; Ian C Grimes; Mark E Benson; Deepak V Gopal; Patrick R Pfau
Journal:  Dig Dis Sci       Date:  2016-12-19       Impact factor: 3.199

Review 3.  Helicobacter pylori Infection, Its Laboratory Diagnosis, and Antimicrobial Resistance: a Perspective of Clinical Relevance.

Authors:  Shamshul Ansari; Yoshio Yamaoka
Journal:  Clin Microbiol Rev       Date:  2022-04-11       Impact factor: 50.129

4.  Evaluation of Better Staining Method among Hematoxylin and Eosin, Giemsa and Periodic Acid Schiff-Alcian Blue for the Detection of Helicobacter pylori in Gastric Biopsies.

Authors:  Abdullah Saleh Alkhamiss
Journal:  Malays J Med Sci       Date:  2020-10-27

5.  Influence of proton pump inhibitors on gastritis diagnosis and pathologic gastric changes.

Authors:  Soumana C Nasser; Mahmoud Slim; Jeanette G Nassif; Selim M Nasser
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

6.  Duodenal intraepithelial lymphocytosis in Helicobacter pylori gastritis: comparison before and after treatment.

Authors:  Dustin E Bosch; Yong-Jun Liu; Camtu D Truong; Kelly A Lloyd; Paul E Swanson; Melissa P Upton; Matthew M Yeh
Journal:  Virchows Arch       Date:  2020-10-06       Impact factor: 4.064

Review 7.  Diagnosis of Helicobacter pylori infection: Current options and developments.

Authors:  Yao-Kuang Wang; Fu-Chen Kuo; Chung-Jung Liu; Meng-Chieh Wu; Hsiang-Yao Shih; Sophie S W Wang; Jeng-Yih Wu; Chao-Hung Kuo; Yao-Kang Huang; Deng-Chyang Wu
Journal:  World J Gastroenterol       Date:  2015-10-28       Impact factor: 5.742

8.  MicroRNA-143-3p, up-regulated in H. pylori-positive gastric cancer, suppresses tumor growth, migration and invasion by directly targeting AKT2.

Authors:  Fang Wang; Jiatao Liu; Yanfeng Zou; Yang Jiao; Yawei Huang; Lulu Fan; Xiaoqiu Li; Hanqing Yu; Chengqun He; Wei Wei; Hua Wang; Guoping Sun
Journal:  Oncotarget       Date:  2017-04-25

9.  A time-saving-modified Giemsa stain is a better diagnostic method of Helicobacter pylori infection compared with the rapid urease test.

Authors:  Chi-Chen Fan; Chung-Hsing Chen; Chi Chou; Ting-Yu Kao; An Ning Cheng; Alan Yueh-Luen Lee; Cheng-Liang Kuo
Journal:  J Clin Lab Anal       Date:  2019-11-15       Impact factor: 2.352

10.  Rapidly declining trend of signet ring cell cancer of the stomach may parallel the infection rate of Helicobacter pylori.

Authors:  Hiroshi Ohyama; Dai Yoshimura; Yosuke Hirotsu; Kenji Amemiya; Hiroyuki Amano; Yuko Miura; Hiroshi Ashizawa; Keiko Nakagomi; Shinya Takaoka; Kenji Hosoda; Yoji Suzuki; Toshio Oyama; Masao Hada; Yuichiro Kojima; Hitoshi Mochizuki; Masao Omata
Journal:  BMC Gastroenterol       Date:  2019-11-08       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.